Free tool
FAERS Monitor: Nicorette
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 022360 or its brand name (Nicorette, Nicotine Polacrilex). Reports on generic versions are filed under their own applications.
Reports
19,243
Serious
3,825
20% of reports
Hospitalization
907
Death reported
148
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective3,355
- nicotine dependence3,000
- intentional drug misuse2,815
- nausea1,649
- drug administration error1,007
- malaise856
- oral discomfort630
- wrong technique in product usage process620
- dizziness590
- dyspepsia573
- macular degeneration568
- headache550
- product quality issue530
- hiccups528
- vomiting514
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 113 |
| 2005 | 188 |
| 2006 | 726 |
| 2007 | 1,058 |
| 2008 | 881 |
| 2009 | 940 |
| 2010 | 947 |
| 2011 | 1,180 |
| 2012 | 1,319 |
| 2013 | 1,064 |
| 2014 | 218 |
| 2015 | 1,302 |
| 2016 | 1,236 |
| 2017 | 1,252 |
| 2018 | 1,068 |
| 2019 | 942 |
| 2020 | 883 |
| 2021 | 1,028 |
| 2022 | 776 |
| 2023 | 656 |
| 2024 | 508 |
| 2025 | 613 |
| 2026 | 345 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,034,916 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| nicotine dependenceSignal | 3,000 | 685.2 | 656.1 | 1,259,920 |
| intentional drug misuseSignal | 2,815 | 169.9 | 163.7 | 409,284 |
| hiccupsSignal | 528 | 75.1 | 68.8 | 36,055 |
| macular degenerationSignal | 568 | 54.5 | 50.2 | 28,390 |
| oral discomfortSignal | 630 | 51.9 | 47.9 | 29,968 |
| drug administration errorSignal | 1,007 | 37.0 | 34.8 | 34,175 |
| dyspepsiaSignal | 573 | 6.4 | 5.9 | 2,601 |
| product quality issueSignal | 530 | 4.3 | 3.9 | 1,331 |
| wrong technique in product usage processSignal | 620 | 3.4 | 3.1 | 1,027 |
| drug ineffectiveSignal | 3,355 | 2.8 | 2.7 | 4,089 |
| nauseaSignal | 1,649 | 2.3 | 2.2 | 1,227 |
| malaiseSignal | 856 | 2.1 | 2.0 | 526 |
| dizziness | 590 | 1.3 | 1.2 | 40 |
| vomiting | 514 | 1.2 | 1.1 | 17 |
| headache | 550 | 1.0 | 0.9 | 1 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.